SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
633.00    13.00 (2.10%)
Bid:
635.00
Ask:
636.00
Spread: 1.00 (0.157%)
Market Cap: £551.50m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Interim Management Statement

25 Jul 2013 07:00

RNS Number : 0479K
Victrex PLC
25 July 2013
 



25 July 2013

Victrex plc - Interim Management Statement

 

'Trading in line with expectations'

 

Victrex plc ('Victrex'), an innovative world leader in high performance thermoplastic polymers, today releases its third quarter Interim Management Statement, covering the period from 1 April 2013 to date.

 

The Company continues to trade in line with market expectations, despite on-going uncertainty in the wider global economy. Group sales volume in the third quarter was 756 tonnes, in line with the previous financial year (Q3 2012: 754 tonnes). Trading in our Invibio Biomaterials business since the half year has been reassuring, with revenue in Q3 ahead of the same period last year.

 

Looking forward, initial order patterns in the fourth quarter across both of our business units continue to be in line with our expectations. There have been no significant changes in the financial position of the Company since it reported its interim results on 28 May 2013.

 

Victrex will host an Investor Day in London on 10 October 2013. Presentations by senior management will focus on strategy and the growth opportunities being developed throughout the Group.

 

Victrex will release its pre-close trading update on 8 October 2013, which will cover the period ending 30 September 2013.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations

Steve Barrow, Group Finance Director

 

01253 898121

01253 897700

 

MHP Communications:

Nick Denton/Barnaby Fry/Ian Payne

 

 

0203 128 8100

 

Investor and analyst call:

A conference call for investors

and analysts will be held today, 25 July 2013 at 09.00am UK time. For more information please contact Rosa Smith at MHP Communications on 0203 128 8560.

 

About Victrex:

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic. With over 30 years of experience, we serve customers across a range of industries, from aerospace, automotive and electronics, to medical and oil and gas, delivering technology driven solutions to the challenges and opportunities they face.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAEXLADPDEFF
Date   Source Headline
4th Jun 20208:54 amRNSAdditional Listing
3rd Jun 20202:52 pmRNSHolding(s) in Company
1st Jun 20202:33 pmRNSBlock listing Interim Review
29th May 202011:58 amRNSTotal Voting Rights
21st May 20203:14 pmRNSHolding(s) in Company
19th May 202010:31 amRNSDirector/PDMR Shareholding
18th May 202010:19 amRNSDirector Declaration
11th May 20207:00 amRNSVictrex plc Interim Results
5th May 20204:13 pmRNSDisclosure of Rights Attached to Equity Shares
5th May 20209:00 amRNSDirector Declaration
30th Apr 202011:39 amRNSTotal Voting Rights
17th Apr 202012:04 pmRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSMarket Update
3rd Apr 20207:00 amRNSDirector Declaration
31st Mar 20209:22 amRNSTotal Voting Rights
24th Mar 20202:00 pmRNSDirectorate Change
17th Mar 20203:32 pmRNSHolding(s) in Company
17th Mar 20202:52 pmRNSDirector/PDMR Shareholding
16th Mar 202010:05 amRNSHolding(s) in Company
12th Mar 202012:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20209:49 amRNSDirector/PDMR Shareholding
28th Feb 202011:56 amRNSTotal Voting Rights
20th Feb 20204:50 pmRNSDirector/PDMR Shareholding
13th Feb 20201:59 pmRNSDirector/PDMR Shareholding
6th Feb 20202:34 pmRNSDirector/PDMR Shareholding
6th Feb 20201:20 pmRNSResult of AGM
6th Feb 202010:54 amRNSDirector/PDMR Shareholding
6th Feb 20207:00 amRNSAGM and Q1 Interim Management Statement
5th Feb 20204:22 pmRNSHolding(s) in Company
4th Feb 20203:42 pmRNSHolding(s) in Company
31st Jan 202010:39 amRNSTotal Voting Rights
20th Jan 202010:04 amRNSDirector/PDMR Shareholding
17th Jan 202010:38 amRNSDirector/PDMR Shareholding
13th Jan 20204:06 pmRNSHolding(s) in Company
13th Jan 20208:46 amRNSJoint Venture
3rd Jan 202012:00 pmRNSAnnual Financial Report
31st Dec 20199:00 amRNSTotal Voting Rights
23rd Dec 20191:44 pmRNSHolding(s) in Company
17th Dec 20192:20 pmRNSDirector/PDMR Shareholding
12th Dec 201910:04 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSPreliminary Results 2019
2nd Dec 20191:52 pmRNSBlock listing Interim Review
29th Nov 201911:38 amRNSTotal Voting Rights
19th Nov 201911:02 amRNSDirector/PDMR Shareholding
12th Nov 201912:00 pmRNSDirectorate Change
31st Oct 201911:36 amRNSTotal Voting Rights
28th Oct 20191:41 pmRNSHolding(s) in Company
18th Oct 20194:01 pmRNSHolding(s) in Company
18th Oct 20192:20 pmRNSDirector/PDMR Shareholding
16th Oct 201911:04 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.